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Abstract: The approach to shock resuscitation focuses on all components of oxygen delivery, including
preload, afterload, contractility, hemoglobin, and oxygen saturation. Resuscitation focused solely
on preload and fluid responsiveness minimizes other key elements, resulting in suboptimal patient
care. This review will provide a physiologic and practical approach for the optimization of oxygen
delivery utilizing available hemodynamic monitoring technologies. Venous oxygen saturation (SvO2 )
and lactate will be discussed as indicators of shock states and endpoints of resuscitation within the
framework of resolving oxygen deficit and oxygen debt.
Keywords: shock; resuscitation; hemodynamic monitoring; fluid responsiveness; stroke volume;
venous oxygen saturation; lactate; oxygen delivery

1. Introduction
Circulatory shock is defined as inadequate oxygen delivery to meet metabolic and oxygen demands [1].
Mechanisms underlying this physiologic emergency are related to decreased cardiac output (CO) due to
either decreased circulating volume (hypovolemic shock), obstruction of circulatory flow (obstructive
shock), or impaired cardiac function (cardiogenic shock). A fourth recognized mechanism is based on the
altered distribution of blood flow leading to perfusion failure (distributive shock). The occurring oxygen
debt and tissue hypoperfusion, regardless of the underlying etiology of the shock, lead to cellular
ischemia and injury and potentially to multi-organ dysfunction syndrome (MODS) and eventual death.
By its definition, the goal in the treatment of shock is, therefore, to increase oxygen delivery
(DO2 ) to meet oxygen demand in order to resolve the global tissue hypoperfusion. Oxygen delivery is
determined by CO and blood oxygen content (CaO2 ) (Figure 1). Therefore, resuscitation of shock at the
bedside is dependent on optimizing the components of CO and CaO2 : Preload, afterload, contractility,
hemoglobin, and oxygen saturation.
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Figure 1. Determinants of oxygen delivery (DO2 ). CO–Cardiac output; CaO2 –Oxygen content;
Figure 1. Determinants
of oxygenSaO
delivery
(DO2). CO–Cardiac output; CaO2–Oxygen content; Hgb–
Hgb–Hemoglobin
concentration;
2 –Oxygen saturation; PaO2 –Partial pressure of oxygen.
Hemoglobin concentration; SaO2–Oxygen saturation; PaO2–Partial pressure of oxygen.
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3. Determining Fluid Responsiveness
3.1. The Frank–Starling Law and Guyton’s Venous Return
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3.2. The Classical Fluid Bolus
There are multiple ways to determine fluid responsiveness. As discussed, the traditional method
based on the Frank–Starling curve is to administer a fluid bolus and determine if SV increases more
than 10%. However, there is much debate on what determines a fluid bolus and how much fluid to
give. Glassford et al. completed a study in which critical care specialists in 30 countries participated
in a practice-based survey to answer what is the definition and expectations of a fluid bolus [15].
More than 80% of clinicians indicated that a fluid bolus is more than 250 mL of either colloid or
crystalloid given over less than 30 min, which resulted in a variety of physiological responses such as
increased mean arterial pressure, decreased heart rate, increased urine output, and other responses.
While common, “more than 250 mL” of “either colloid or crystalloid” has been a non-specific application
of Frank–Starling law with continuing debate.
Crystalloids, specifically Ringer’s lactate or isotonic saline, are commonly selected for initial fluid
resuscitation in the hypotensive patient. A pitfall of this fluid selection is that the volume expanding
effects are transient. In comparison, colloids are known to optimize the amount of fluid that remains
in the intravascular space and thus can restore volume faster and for a longer amount of time [16].
The CRISTAL trial did not show a difference in 28-day mortality between patients given crystalloids
versus colloids in critically ill patients with hypovolemia, however, there were fewer deaths at 90 days
in the colloid group [17]. For septic shock, the Surviving Sepsis Campaign guidelines suggest the
addition of albumin when patients require significant amounts of crystalloids during resuscitation but
recommend against the use of the hydroxyethyl starches as these may increase the risk of acute kidney
injury and death [18].
3.3. The 5-2-0 Rule
While an absolute CVP target is not recommended, the late Dr. Max Harry Weil first described
the 5-2-0 rule using CVP to evaluate fluid responsiveness [19]. This technique involves first observing
CVP for 10 min and then delivering a fluid bolus based on the initial CVP. If CVP < 8 cm H2 O, then a
200 mL bolus is administered over 10 min. If CVP ≤ 14 cm H2 O, then a 100mL bolus is administered,
and if CVP > 14 cm H2 O, a 50 mL bolus is given. During minutes 0–9 of infusion, if CVP increases by
>5 cm H2 O, then infusion is stopped. After infusion is complete, if CVP increases by 2–5 cm H2 O then
fluids are stopped. If CVP increases by <2 cm H2 O, then infusion is continued as the patient is still
fluid responsive.
3.4. Inferior Vena Cava (IVC) Collapsibility
Targeting CVP and SV have required inserting a central venous or pulmonary artery catheter,
which may be impractical, especially when a patient first presents in the emergency department. Thus,
clinicians have trended towards utilizing inferior vena cava (IVC) collapsibility as a bedside method
for determining fluid responsiveness. Using ultrasound, fluid status can be evaluated by measuring
the IVC diameter [20,21].
When the IVC is under-filled, there is a greater compliance of the vessel, resulting in a collapse
during spontaneous inspiration. In hypovolemic states, the pressure gradient between the thoracic
portion of the IVC and abdominal portion of the IVC is greatest, which forces blood out of the IVC
and into the right atrium. Typically, an IVC diameter ≤ 2.1 cm and > 50% collapsible correlates with
CVP 0–5 mm Hg. IVC diameter > 2.1 cm and < 50% collapsible correlates to CVP 10–20 mm Hg [22].
Limitations of this technique, as with any ultrasound application, include operator expertise and
variability when obtaining IVC images. Additionally, the same physiologic limitations of CVP as a
measure of preload apply to the IVC since “normal” heart–lung parameters are often not present in
critically ill patients.
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3.5. Passive Leg Raise (PLR)
The passive leg raise (PLR) maneuver provides an artificial fluid bolus, and thus reduces the risk
of inappropriate administration of fluids in patients who are not fluid responsive. This technique
involves raising the patient’s leg from flat to 45◦ position for 5 min in order to transfer blood from
the lower extremities to the thoracic cavity and approximates a 200–300 mL fluid bolus. Bentzer et al.
performed a meta-analysis analyzing 2260 patients and found that PLR effectively identified patients
whose CO would be augmented by the administration of a fluid bolus (pooled specificity, 92%) and PLR
also effectively identified those patients who would not be fluid responsive (pooled sensitivity,
88%) [3]. However, while there is significant data to support the accuracy of the PLR for
predicting fluid responsiveness, Chopra et al. sought to examine the precision of predicting fluid
responsiveness with PLR determined by the non-invasive cardiac output monitoring technology,
NiCOM™ (Cheetah Medical, Inc., Newton Center, MA 02459, USA) [23]. Their study found a 9%
standard deviation in the precision of determining the change in SV after the PLR maneuver in both
critically ill patients and healthy volunteers. Their results raised the question of having a strict cutoff
SV increase by 10% to identify fluid responsiveness.
3.6. Stroke Volume Variation (SVV) and Pulse Pressure Variation (PPV)
Taking into account the heart–lung interactions to determine fluid responsiveness may avoid
the need to perform a maneuver such as PLR or to administer a potentially harmful fluid bolus.
Spontaneously breathing patients who are hypovolemic will have a greater reduction in SV and blood
pressure at the end of inspiration, similar to pulsus paradox in patients with cardiac tamponade
(or obstructive shock). In the setting of mechanical ventilation, as positive pressure is introduced to the
thorax, there is a rise in pleural pressure, which decreases venous return and leads to a reduction in right
ventricle preload. Right ventricular afterload (increased pulmonary vascular resistance) also increases,
resulting in decreased right ventricular stroke volume. Conversely, the increase in transpulmonary
pressure is thought to increase left ventricular preload as blood is essentially squeezed out of the
pulmonary vasculature and into the left ventricle. Left ventricular afterload decreases because positive
pleural pressure causes a decrease in thoracic blood volume; therefore, resulting in an increased left
ventricular stroke volume during inspiration.
Because of the approximately two-second pulmonary transit time, the inspiratory decrease in
right ventricular stroke volume causes a decrease in left ventricular stroke volume a few heart beats
later during expiration [24,25]. Recognizing this physiology, stroke volume variation (SVV) or pulse
pressure variation (PPV) is the difference between the maximal (inspiratory) and minimal (expiratory)
stroke volume or pulse pressure, respectively, over 3 to 5 breaths divided by the average [8]. Studies
have shown that SVV or PPV > 10–12% is indicative of fluid responsiveness; i.e., SV increase >15% in
response to a fluid bolus administration [26,27].
PPV can be measured via arterial based systems and derived through arterial waveform analysis.
SVV is computed by proprietary algorithms via the area under the systolic pressure curve. Limitations
of SVV and PPV measurements are that they have only been validated in patients without arrhythmias,
on mechanical ventilation without spontaneous respiration and with high tidal volumes > 8 mL/kg [28].
4. Measuring Stroke Volume and Cardiac Output
4.1. Indicator Dilution Methods
If the purpose of increasing preload is to increase SV, then we must have bedside techniques to
measure changes in SV after fluid administration. Thermodilution via the pulmonary artery catheter is
considered the “gold standard” in SV and CO measuring techniques. This method is used to derive
SV based on how rapidly a cold injectate warms (or becomes diluted) over time. Boluses of ice-cold
fluid are injected into the right atrium, and blood temperature is measured by a thermal filament
on the catheter in the pulmonary artery and used to calculate SV [7,29]. A similar technique uses a
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lithium (instead of cold fluid) injectate into the central venous catheter. A lithium sensitive sensor
attached to a peripheral arterial line then detects the concentration of lithium ions in the arterial blood;
the “wash-out curve” is then used to derive SV.
4.2. Arterial Waveform/Pulse Contour Analysis
Given the invasiveness of inserting a pulmonary artery catheter to measure SV and CO, a minimally
invasive method of analyzing the continuous artery pressure waveform has become popular in recent
years. These systems use blood flow sensors connected to an arterial line that analyzes arterial
pulsatility and converts pressure-base signals into flow measurements from which SV and CO can
be derived. Importantly, several technologies have been developed to calculate SVV and PPV based
on the information derived from arterial waveform analysis, therefore, making this hemodynamic
monitoring technique attractive [30].
However, there is ongoing debate surrounding the accuracy and outcome benefits provided by
this technology. CO measurements may be “uncalibrated,” which indicates the values are calibrated
to biometric or physiological data from large patient datasets. “Calibrated” values are calibrated to
an external reference measurement of CO, such as indicator dilution methods in the same patient.
Regardless of the calibration method, it has been shown that CO measurements by pulse contour analysis
are inaccurate in situations of hemodynamic stability. Therefore, the timing for recalibration is crucial
and should be made on a case by case basis [31]. Peyton et al. performed a pool-weighted meta-analysis
of 4 methods of cardiac output measurements, including pulse contour analysis, and found that all of
the methods lacked the percentage error limit of 30% in agreement with thermodilution measured
CO [32].
4.3. Transthoracic (TTE) and Transesophageal Echocardiography (TEE)
SV can be calculated by multiplying the area of the aortic valve by the velocity–time integral
of a Doppler signal across the left ventricular outflow tract; essentially, volume = area × distance.
This can be accomplished with either transthoracic or transesophageal echocardiography. Limitations
are similar to those mentioned above for measuring LVEDV. Limitations of TEE include esophageal
intubation with a flexible probe, which is not well tolerated in patients who are awake. Additionally,
the probe must be properly positioned before each measurement [33].
4.4. Bioimpedance and Bioreactance
The concept of bioimpedance can be understood in terms of Ohm’s law, where the flow of current
(I) is equal to the voltage (V) drop between the two ends of a circuit, divided by the impedance or
resistance (R) (I = V/R). Impedance is related to changes in volume, and these changes in volume can
be used to calculate SV. As blood flows through the thorax with each cardiac cycle, a high-frequency,
low-magnitude current is passed across the thorax, which can be measured with electrodes. Stroke
volume can then be calculated using mathematical algorithms. Bioreactance was developed to
measure changes in the frequency of the electric currents; the advantage of this being the reduction of
background noise [34]. Limitations include the requirement of proper patient positioning and electrode
placement for accurate measurements. Critically ill patients may have multiple factors contributing to
changes in thoracic impedance, and thus these techniques are likely more accurate in relatively stable
patients [35–38].
4.5. Transcutaneous/Transesophageal Doppler
The principle of the Doppler effect is based on the flow velocity of red blood cells. As blood flows
through a vessel, RBCs emit and reflect ultrasound waves. The difference between the frequencies
of these waves is proportional to the velocity of the red blood cells. An ultrasound probe placed at
the sternal notch can measure Doppler flow across the aortic or pulmonary valve to measure SV and
CO. Some studies suggest this method is reliable regardless of heart rhythm, ventilator, or vasoactive
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agents, and thus can be considered ideal for non-invasive monitoring. Other studies suggest a lack of
correlation with standard TTE [39–41]. Advantages include good interrater reliability regardless of the
level of training [42,43].
Alternatively, a transesophageal Doppler method can be used for continuous monitoring of
SV and CO with an esophageal probe placed adjacent to the descending aorta. This technique has
been validated by multiple studies, including surgical patients and those receiving positive pressure
ventilation [44,45]. Limitations include the need for the Doppler signal to be continuously measured at
the same angle with frequent adjustments at the bedside.
5. Optimizing Afterload
We often use mean arterial pressure (MAP) as a surrogate for afterload, keeping in mind that MAP
= CO × systemic vascular resistance (SVR). Once we have optimized SV and CO to the plateau region
of the Frank–Starling curve, then low MAP must indicate low SVR. Therefore, in cases of septic shock,
vasopressor agents may be required to increase SVR. Conversely, in cases of cardiogenic shock or acute
heart failure, SVR may be high and vasodilator agents can be used to decrease afterload and increase
CO. Based on the Surviving Sepsis Guidelines, the first-line vasopressor used for patients in septic
shock should be norepinephrine [46]. Second-line agents include vasopressin and epinephrine, when
norepinephrine is not sufficient to achieve MAP goals. Vasopressin should be used at 0.03 U/min and
should not be used as the only vasopressor. Because epinephrine stimulates anaerobic metabolism in
skeletal muscle, it may increase lactate levels rendering lactate a less ideal indicator of hypoperfusion.
Phenylephrine should only be used as a third-line agent in septic shock. Its side effect of bradycardia
may be helpful in patients with severe tachycardia or at risk for tachyarrhythmia, such as atrial
fibrillation. Dobutamine may be used for patients having low CO while on vasopressors with
preserved MAP, but still showing evidence of inadequate perfusion.
Afterload reducing agents (vasodilators) may be used in the setting of heart failure or cardiogenic
shock. In patients with acute decompensated heart failure, intravenous nitrates are first-line agents.
Nitroprusside decreases preload and afterload and is useful in patients with severe hypertension. The
metabolite of nitroprusside is cyanide and thus majorly limits its use. Nitroglycerin reduces preload
more than afterload and is ideal in patients with heart failure and low CO. Other afterload reducing
agents include intravenous hydralazine, which should be used cautiously as it may cause reflex
tachycardia, and is not ideal in patients with underlying coronary artery disease or aortic dissection.
Enalaprilat is an angiotensin-converting enzyme inhibitor in intravenous form that is another afterload
reducing agent. It should be avoided in patients with acute myocardial infarction, hyperkalemia, and
renal artery stenosis [47,48].
In the critically ill patient, a target MAP goal of 65–75 mm Hg is appropriate. For septic shock
patients undergoing resuscitation, there is no mortality difference in targeting MAP 65–70 mm Hg
versus 80–85 mm Hg [49]. Recently, the COMACARE trial compared low normal MAP (65–75 mm Hg)
with high normal MAP targets (80–100 mm Hg) in post-cardiac arrest and saw no difference in markers
of cerebral or myocardial injury, EEG findings, and neurologic outcome [50].
6. Improving Contractility
Once preload and afterload are optimized, contractility needs to be addressed in order to
increase SV further and, therefore, DO2 . It must be recognized, however, that not all patients need
their Frank–Starling curve to be “pushed up.” Each patient has an intrinsically acceptable SV and
CO; and there is no universally accepted “normal.” Cattermole et al. used ultrasound to evaluate
hemodynamic parameters of over 2000 subjects ranging in age from 1 to 89 years. CO varies among
age and weight, and even significantly within age groups [51]. Thus, increasing SV by increasing
contractility is not always the answer when trying to optimize DO2 . Furthermore, before increasing
contractility we need to ensure oxygen content is optimized, as increasing contractility increases
myocardial oxygen demands.
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7. Increasing Arterial Oxygen Content
Arterial oxygen content (CaO2 ) is a product of hemoglobin, arterial oxygen saturation (SaO2 ),
and partial pressure of oxygen (PaO2 ). While increasing SaO2 naturally increases DO2 , the ideal oxygen
saturation is not known and may vary based on the patient’s co-morbidities and disease process.
In patients with traumatic brain injury, a higher PaO2 increases oxygen tension, thus optimizing the
diffusion of dissolved plasma oxygen into brain tissue [52]. However, studies suggest that we should
limit the PaO2 levels of critically ill patients within a safe range. A PaO2 greater than 200 mm Hg is
associated with higher mortality since hyperoxia increases the risk of tissue damage by reactive oxygen
species as well as hyperoxia-induced vasoconstriction [53]. In mechanical ventilation, a conservative
oxygen therapy approach targeting SpO2 90–97% showed no difference in ventilator-free days [54].
A systematic review and meta-analysis of 25 randomized controlled trials showed that oxygen therapy
to SpO2 greater than 94% was associated with increased mortality [55]. Thus, a recent clinical practice
guideline recommends a target SpO2 range 90–94% in most critically ill patients [56].
There is still debate surrounding the role of transfusion in shock. The landmark Transfusion
Requirements in Critical Care (TRICC) trial randomized 838 critically ill patients to receive either
a restrictive (transfuse for Hgb < 7 mg/dL) or liberal (transfuse for Hgb < 9 mg/dL) transfusion
strategy [57]. Overall there was no difference in the primary outcome of 30-day mortality, but a benefit
with liberal transfusion was shown in those patients under age 55 and patients with APACHE II
≤ 20. Conversely, there was increased mortality in the liberal arm in those patients with ischemic
heart disease. The Transfusion Requirements in Septic Shock (TRISS) trial, however, showed similar
outcomes related to mortality and ischemic events in liberal versus restrictive transfusion [58].
Generally, transfusion will improve oxygen delivery in life threatening anemia, as severe anemia
eventually leads to a critical level of oxygen delivery requiring intervention. However, there still
remains controversy regarding the degree in which transfusion improves tissue oxygenation in
moderate anemia (hemoglobin 7–10 g/dL), since normal physiologic mechanisms such as increased
cardiac output and increased oxygen extraction at the tissue level allow for compensation in the setting
of moderate anemia. In addition, notable is the importance of maintaining normovolemia when
transfusing an anemic patient, as red blood cells increase blood viscosity and have been shown to
decrease cardiac output if hematocrit becomes significantly elevated. In such a situation, the additional
red blood cells become ineffective transporters of oxygen to the tissue [59].
8. Targeting Contractility and Hemoglobin Guided by SvO2 or ScvO2
The decision to initiate inotropic support such as with dobutamine and/or to transfuse can be
guided by venous oxygen saturation (SvO2 ) measured at the pulmonary artery. Central venous oxygen
saturation (ScvO2 ) measurements, obtained in the superior vena, can be used as a surrogate to SvO2
and more feasibly measured with a central venous catheter. ScvO2 parallels SvO2 but is on average
7 ± 4% higher [60]. SvO2 reflects the relationship between oxygen consumption and oxygen delivery,
as described by the “Oxygen Choo-Choo Train” model (Figure 4).
The Oxygen Choo-Choo Train model describes the relationship between CO, oxygen content,
and the consumption of oxygen (VO2 ) [61]. The engine represents CO, and the train cars represent
hemoglobin carrying oxygen for delivery. The “oxygen consumption station” is where oxygen is
extracted and consumed at the level of the tissues. After leaving the “oxygen consumption” station,
the train then carries venous blood (usually ~75% of arterial oxygen content) back to the lungs or
“oxygen loading station”.
If a patient has low SvO2 , then there is either a decrease in DO2 or an increase in VO2 . Decreased
DO2 may be due to anemia, hemorrhage, hypoxia, hypovolemia, or cardiac failure; whereas, increased
VO2 can be caused by agitation, fever, pain, shivering, respiratory muscle work, or any increase in
metabolic demand [62]. In relation to the Choo-Choo Train model, there is either a problem with
the train or an increase in VO2 at the station. Patients with low SvO2 and high CO may be anemic
(requiring transfusion) or hypoxemic (requiring mechanical ventilation). In this scenario, the engine
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(CO) is going at the proper speed, but there are not enough train cars (hemoglobin) to carry oxygen
or not enough oxygen on the train cars. At the tissue level, the maximum oxygen extraction ratio is
~50%; thus, if SvO2 < 50%, then low DO2 must be a contributor, not just high VO2 . Patients with low
SvO2 and low CO may be in cardiogenic shock requiring inotropes. In relation to the Choo-Choo Train
model, inotropes can be seen as an enhancement to the engine. At the bedside, when SvO2 is low,
strategies to decrease VO2 should be considered first, such as analgesia, sedation, antipyretic, or even
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intubation,
prior to increasing DO2 with blood transfusion or inotropes.
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9. SvO2 and Lactate as Indicators of Shock and Resuscitation Endpoints
The Oxygen Choo-Choo Train model describes the relationship between CO, oxygen content,
As discussed, SvO2 reflects the relationship between VO2 and DO2 , and helps identify if CO is
and the consumption of oxygen (VO2) [61]. The engine represents CO, and the train cars represent
sufficient to meet metabolic demands. Importantly, SvO2 reflects the oxygen deficit that occurs in
hemoglobin carrying oxygen for delivery. The “oxygen consumption station” is where oxygen is
shock. The concept of the oxygen deficit was first described in 1964 as the integral difference between
extracted and consumed at the level of the tissues. After leaving the “oxygen consumption” station,
the rates of oxygen usage before and after the onset of shock [63]. When there is an inadequate DO2
the train then carries venous blood (usually ~75% of arterial oxygen content) back to the lungs or
to meet oxygen demand (low SvO2 ), or when oxygen utilization is impaired from extraction defects
“oxygen loading station”.
(high SvO2 ), an oxygen deficit develops. It is calculated as a difference between the baseline VO2 and
If a patient has low SvO2, then there is either a decrease in DO2 or an increase in VO2. Decreased
VO2 measured at a particular time point during shock. Therefore, SvO2 represents a snapshot of an
DO2 may be due to anemia, hemorrhage, hypoxia, hypovolemia, or cardiac failure; whereas,
oxygen deficit. Continuous monitoring of SvO2 allows for minute-to-minute resolution of the ongoing
increased VO2 can be caused by agitation, fever, pain, shivering, respiratory muscle work, or any
oxygen deficit.
increase in metabolic demand [62]. In relation to the Choo-Choo Train model, there is either a
If the oxygen deficit is not addressed and allowed to persist, an oxygen debt develops, or an
problem with the train or an increase in VO2 at the station. Patients with low SvO2 and high CO may
accumulation of multiple oxygen deficits over time [64]. This occurs when VO2 remains persistently low
be anemic (requiring transfusion) or hypoxemic (requiring mechanical ventilation). In this scenario,
due to inadequate DO2 , resulting in global tissue hypoxia and lactate production. As a compensatory
the engine (CO) is going at the proper speed, but there are not enough train cars (hemoglobin) to
mechanism, oxygen extraction can increase to maintain VO2 while DO2 is being optimized. However,
carry oxygen or not enough oxygen on the train cars. At the tissue level, the maximum oxygen
a persistently elevated lactate suggests that the oxygen debt is unmet.
extraction ratio is ~50%; thus, if SvO2 < 50%, then low DO2 must be a contributor, not just high VO2.
Based on the above understanding, low SvO2 and high lactate levels indicate ongoing shock
Patients with low SvO2 and low CO may be in cardiogenic shock requiring inotropes. In relation to
when DO2 falls below the critical oxygen delivery threshold to meet the required VO2 in the tissues.
the Choo-Choo Train model, inotropes can be seen as an enhancement to the engine. At the bedside,
Increasing oxygen extraction alone is not adequate, and measures to increase DO2 above the critical
when SvO2 is low, strategies to decrease VO2 should be considered first, such as analgesia, sedation,
threshold are necessary (Figure 5).
antipyretic, or even intubation, prior to increasing DO2 with blood transfusion or inotropes.
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that fluid boluses transiently increase intravascular volume, but eventual extravascular fluid shifts
shift unstressed volume to stressed volume, which then drives tissue perfusion. However, vasopressors
have potential deleterious effects including organ ischemia and increased myocardial oxygen demand.
Recent studies suggest there is no difference in survival between liberal versus restrictive fluid
resuscitation strategies [69,70]. Additionally, the early use of norepinephrine instead of fluids was
associated with a lower incidence of cardiogenic pulmonary edema and new onset arrhythmia [69].
However, a restrictive fluid approach may increase the risk of acute kidney injury [70]. The ongoing
CLOVERS trial comparing liberal fluids versus early vasopressor in septic shock resuscitation will
hopefully provide further evidence and consensus on these strategies [71].
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11. Putting It All Together
In summary, resuscitation of shock includes optimizing preload, afterload, contractility,
In summary, resuscitation of shock includes optimizing preload, afterload, contractility,
hemoglobin, and oxygen saturation. This is the fundamental principle behind the Early Goal-Directed
hemoglobin, and oxygen saturation. This is the fundamental principle behind the Early Goal-Directed
Therapy (EGDT) protocol for septic shock [72]. EGDT includes targeting CVP of 8–12 mm Hg
Therapy (EGDT) protocol for septic shock [72]. EGDT includes targeting CVP of 8–12 mm Hg
(optimizing preload), MAP goals 65-90 mm Hg (optimizing afterload), and ScvO2 > 70% (optimizing
(optimizing preload), MAP goals 65–90 mm Hg (optimizing afterload), and ScvO2 > 70% (optimizing
contractility via inotropes and oxygen saturation/hemoglobin via transfusion or mechanical
contractility via inotropes and oxygen saturation/hemoglobin via transfusion or mechanical ventilation),
ventilation), with the goal of restoring tissue oxygenation and repaying oxygen debt within the first
with the goal of restoring tissue oxygenation and repaying oxygen debt within the first 6 h. It is
6 h. It is important to realize these concepts are applicable to other types of shock (cardiogenic,
important to realize these concepts are applicable to other types of shock (cardiogenic, hypovolemic)
hypovolemic) as the goal of therapy is to provide adequate oxygen delivery. This structured approach
as the goal of therapy is to provide adequate oxygen delivery. This structured approach provides an
provides an overall framework for resuscitation with physiologic sound endpoints.
overall framework for resuscitation with physiologic sound endpoints.
Contemporary multi-center clinical trials (ProCESS, ARISE, and ProMISe) have compared
Contemporary multi-center clinical trials (ProCESS, ARISE, and ProMISe) have compared standard
standard therapy to EGDT and showed no difference in clinical outcomes in septic shock [73–75].
therapy to EGDT and showed no difference in clinical outcomes in septic shock [73–75]. Unfortunately,
Unfortunately, these results have led to a sea change of clinicians abandoning the fundamental
these results have led to a sea change of clinicians abandoning the fundamental principles of oxygen
principles of oxygen transport as it relates to shock management and initial resuscitation. For septic
transport as it relates to shock management and initial resuscitation. For septic shock, treatment at
shock, treatment at the bedside has been minimized to “usual care”. We are not clear what usual care
the bedside has been minimized to “usual care”. We are not clear what usual care means or how to
means or how to teach it to the next generation of clinicians. However, on further examination, these
teach it to the next generation of clinicians. However, on further examination, these aforementioned
aforementioned trials have also taught us that different hemodynamic phenotypes exist in septic
trials have also taught us that different hemodynamic phenotypes exist in septic shock, reflected by the
shock, reflected by the ScvO2 and lactate levels of patients enrolled (Figure 6).
ScvO2 and lactate levels of patients enrolled (Figure 6).
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did not show benefit with EGDT in various subgroups of illness severity, there was no comparison
between EGDT versus usual care for the subgroups of low, normal, and high ScvO2 [77]. Given our
understanding of shock, this different phenotype in the Trio Trials may not have an oxygen deficit
nor oxygen debt. Applying the physiologic principles discussed here, one can critically examine the
evidence presented in these and future shock resuscitation trials. Were patients truly in shock or
already partially resuscitated? In those patients without ongoing oxygen deficit, usual care without
targeting all the components of DO2 may be adequate. Thus, it was not surprising that EGDT did not
show any outcome benefit in the Trio Trials. However, the phenotype with significant oxygen debt
when examined by Protti et al. has shown outcome benefits almost identical to the EGDT trial [78].
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In the ALBIOS trial, all patients received EGDT to target ScvO2 > 70%. Persistence of low ScvO2 was
associated with higher 90-day mortality, possibly because it reflected underlying cardiac dysfunction.
The authors concluded that subjects with ScvO2 < 70% may benefit most from interventions aimed at
normalizing the balance between systemic oxygen delivery and consumption.
While EGDT may not be effective in the less sick patients, we should not forget the concepts of
shock resuscitation presented in this review. Focusing solely on preload and its responsiveness without
addressing the other components of DO2 in a severe shock patient is intuitively inappropriate. Shock
will only progress to increasing lactic acidosis, multi-organ failure requiring multiple vasopressors,
and death. Shock treatment should not be minimized to a mere passive leg raise and a debate on when
to give the fluid bolus, but rather be considered in the broader context of optimizing oxygen delivery
to meet the oxygen demand with appropriate assessment of the different hemodynamic components.
We will conclude our review with a case example to illustrate how we can apply the various
technologies available to treat a patient with septic shock optimally.
Case Example
A 67-year-old female with a past medical history of diabetes, hypertension, end-stage renal
disease on dialysis, and congestive heart disease presented to the emergency department complaining
of fever and productive cough for the last week. Her primary physician prescribed her a “Z-pack”
5 days ago, however, her symptoms did not improve. Her vital signs included temperature 38.3
◦ C, heart rate 132 beats per min, respiratory rate 28 breaths per min, blood pressure 84/43 mm Hg,
SpO2 92%, and weight 85 kg. Her physical exam included significant bibasilar crackles, otherwise
unremarkable. Her laboratories showed a white blood cell count 18,300 per µL, hemoglobin 7.9 g/dL,
platelets 156,000 per µL, creatinine 4.6 mg/dL, and glucose 232 mg/dL. Lactate was 7.4 mmol/L and
procalcitonin 4.3 ng/mL. Her chest radiograph showed bilateral lower lobe consolidations consistent
with severe pneumonia.
Given the patient’s significant tachycardia and hypotension, an immediate 30 mL/kg crystalloid
fluid bolus was given via a peripheral intravenous catheter. Her blood pressure improved to 90/52 mm
Hg (or MAP 65 mm Hg). Without vasopressor administration requiring a central venous catheter yet,
monitoring preload and assessing fluid responsiveness can be achieved with ultrasound measurements
of the IVC collapsibility. Alternatively, the bioreactance technology can be used to monitor SV and CO.
A PLR maneuver or an additional crystalloid fluid bolus of 500 mL can be administered to determine
fluid responsiveness by calculating the change in stroke volume index (∆SVI) before and after the PLR
or fluid bolus.
After 2 additional liters of crystalloid fluid boluses, the patient became more hypotensive with
blood pressure 78/45 mm Hg (or MAP 56 mm Hg). A central venous catheter (CVC) with continuous
ScvO2 capability was inserted in her right subclavian vein. The subclavian vein approach was chosen
over the internal jugular vein since the catheter can be inserted quickly without the need of ultrasound
guidance. An arterial catheter was inserted in her left radial artery. Norepinephrine was initiated and
the dose was quickly increased to 15 mcg/min. With the CVC in place, CVP monitoring should be
started. Her CVP was 6 mm Hg with ScvO2 55%. Her recent ∆SVI was 18%. Additional 2 L of fluids
were administered to reach CVP 10 mm Hg, MAP 68 mm Hg, and ScvO2 58%. Her heart rate also
decreased to 95 beats per minute.
Her CO on the bioreactance monitor was 3.8 L/min, with ∆SVI 8% after the most recent fluid
bolus. With the arterial catheter in place, an alternative technology of arterial waveform analysis could
be used to monitor CO; however, we decided to continue with bioreactance CO measurements. If the
patient required intubation and mechanical ventilation, then SVV monitoring with arterial waveform
analysis to determine fluid responsiveness may be preferred over repeated measurements of ∆SVI
determined by PLR maneuvers.
At this point, the patient’s hemodynamic status seemingly appeared stable on norepinephrine and
was no longer fluid responsive. However, her ScvO2 remained low. A repeat lactate measurement was
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5.6 mmol/L. Given ScvO2 < 70% and lactate > 4 mmol/L, we targeted a higher hemoglobin > 9–10 g/dL
with transfusion of 2 units of packed red blood cells. After transfusion her ScvO2 increased to 63%.
The persistently low ScvO2 and low CO required us to initiate dobutamine at 5 and then 10 mcg/kg/min.
Her ScvO2 then normalized to 72%, with CO 6.2 L/min. The patient then met her resuscitation endpoints
with another repeat lactate 2.8 mmol/L, showing a lactate clearance of 62%. She was admitted to the
intensive care unit. Cultures showed that the patient had Klebsiella pneumonia. Norepinephrine and
dobutamine were titrated off within 48 h, and patient was discharged home after 5 days.
In summary, based on our application of oxygen transport physiology at the bedside, we utilized
the available hemodynamic monitoring tools to optimize CVP, MAP, CO, ∆SVI, and ScvO2 in order to
increase DO2 and resolve the oxygen debt present in septic shock. Without this comprehensive approach,
the patient would not have received the required amount of fluids, vasopressor, blood transfusion,
and inotrope. Performing repeated PLR maneuvers may address the inadequate preload with a
transient decrease in lactate. However, if a vasopressor is initiated without resolving the imbalance
between DO2 and VO2 reflected by a decreased ScvO2 , oxygen debt and lactate elevation will continue.
Shock will only progress to multi-organ failure and death.
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